Skip to content
Saturday, November 14, 2026
Explore a vibrant collection of creative writing, photograp…

The Zimbabwean Government Turns Down ‘One-Sided’ US Healthcare Assistance Agreement Over Data Concerns

Health aid illustration
The proposed US funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) spanning five years because of Washington's insistence on sensitive biological samples.

This rejection came to light after a official document from December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "skewed".

An official spokesperson has since explained that the United States was demanding access to health data for scientific study and profit but was unwilling to guarantee the resulting advantages from any future treatments.

"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged more dialogue to find a agreement agreeable to both sides so the country's vital HIV programme can proceed.

Broader Background

This development follows a comparable situation in Kenya, where a high court halted a similar health funding agreement after concerns were raised about the safety of Kenyans' health data.

After returning to office last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and responsibility.

Based on statements, 16 African countries have so far agreed to similar agreements, representing over $18.3bn in new funding.

Specifics of the Declined Agreement

The funds for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"Effectively, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be accessible to our people if a new health crisis emerge."

Sovereignty and Global Health

He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting structures previously established through the international health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.

"This mechanism is designed to ensure that when a country provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

These objections regarding the US deal "are not meant as anti-American sentiment," he added.

"We welcome further dialogue with our US partners on how future co-operation could be arranged in a manner that honours the independence and interests of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but suggested that negotiations must proceed given that a large portion of the country's HIV programmes depended on external financing.

"In cases where technical issues arise, including those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," the group said.

The halted deal highlights the complex debate between accepting vital international aid and safeguarding local interests in an increasingly data-driven world.

Written by

Edwin Burnett

Maya Sterling is a freelance writer and photographer with a passion for storytelling and visual arts, based in Portland.

Vivid Journal

Type to search articles.